Both in Pharmaceuticals
Monopar Therapeutics vs Faeth Therapeutics
Over the past year MNPR returned −34.8% and FTH returned −49.9%; their daily moves had a correlation of 0.34.
MNPR −34.8% FTH −49.9%Growth of $1, one year, split-adjusted
| Metric | MNPR | FTH |
|---|---|---|
| Price | $71.91 | $18.75 |
| Market cap | $482.7M | $484.5M |
| Today | −2.02% | −2.34% |
| 1 month | −9.7% | −37.0% |
| 6 months | +37.9% | — |
| Year to date | +10.1% | — |
| 1 year | −10.0% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $134.3M | $186.4M |
| Dividend yield | — | — |
| Volatility (60d) | 49.2% | — |
| Short % of float | 23.3% | 16.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).